Detalles de la búsqueda
1.
CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma.
Blood
; 128(7): 959-70, 2016 08 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-27307294
2.
Establishing human leukemia xenograft mouse models by implanting human bone marrow-like scaffold-based niches.
Blood
; 128(25): 2949-2959, 2016 12 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27733356
3.
Phase 1/2 study of lenalidomide combined with low-dose cyclophosphamide and prednisone in lenalidomide-refractory multiple myeloma.
Blood
; 128(19): 2297-2306, 2016 11 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27647864
4.
Effect of daratumumab on normal plasma cells, polyclonal immunoglobulin levels, and vaccination responses in extensively pre-treated multiple myeloma patients.
Haematologica
; 105(6): e302-e306, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31558675
5.
Reconstructing the human hematopoietic niche in immunodeficient mice: opportunities for studying primary multiple myeloma.
Blood
; 120(3): e9-e16, 2012 Jul 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-22653974
6.
Inability of monoclonal anti-light chain antibody to detect clonal B-cells in a patient with follicular lymphoma by multicolor flow cytometry.
J Clin Lab Anal
; 28(6): 493-5, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24659431
7.
Lethal neonatal bone marrow failure syndrome with multiple congenital abnormalities, including limb defects, due to a constitutional deletion of 3' MECOM.
Haematologica
; 103(4): e173-e176, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29439187
8.
Cereblon loss and up-regulation of c-Myc are associated with lenalidomide resistance in multiple myeloma patients.
Haematologica
; 103(8): e368-e371, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29545338
9.
Defective calcium signaling and disrupted CD20-B-cell receptor dissociation in patients with common variable immunodeficiency disorders.
J Allergy Clin Immunol
; 129(3): 755-761.e7, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22130422
10.
CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia.
J Allergy Clin Immunol
; 129(3): 787-793.e6, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22197273
11.
Impact of treatment reduction for childhood acute lymphoblastic leukemia on serum immunoglobulins and antibodies against vaccine-preventable diseases.
Pediatr Blood Cancer
; 58(5): 701-7, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21793184
12.
Changes in lymphocyte subsets in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Occup Environ Med
; 69(11): 781-6, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22843439
13.
Immune reconstitution in children following chemotherapy for haematological malignancies: a long-term follow-up.
Br J Haematol
; 152(2): 201-10, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21114483
14.
Lymphocyte characteristics in children with common variable immunodeficiency.
Clin Immunol
; 135(1): 63-71, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20006554
15.
An inkjet-printed polysaccharide matrix for on-chip sample preparation in point-of-care cell counting chambers.
RSC Adv
; 10(31): 18062-18072, 2020 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35517228
16.
Measurement of pneumococcal polysaccharide vaccine responses for immunodeficiency diagnostics: combined IgG responses compared to serotype specific IgG responses.
J Clin Immunol
; 34(1): 3-6, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23881353
17.
Inhibition of the mevalonate pathway potentiates the effects of lenalidomide in myeloma.
Leuk Res
; 33(1): 100-8, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18621417
18.
A bioluminescence imaging based in vivo model for preclinical testing of novel cellular immunotherapy strategies to improve the graft-versus-myeloma effect.
Haematologica
; 93(7): 1049-57, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18492693
19.
All-printed cell counting chambers with on-chip sample preparation for point-of-care CD4 counting.
Biosens Bioelectron
; 117: 659-668, 2018 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30005387
20.
Lenalidomide combined with low-dose cyclophosphamide and prednisone modulates Ikaros and Aiolos in lymphocytes, resulting in immunostimulatory effects in lenalidomide-refractory multiple myeloma patients.
Oncotarget
; 9(74): 34009-34021, 2018 Sep 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30338042